Welcome to the ValueWiki Arrowhead Research Corporation (ARWR) article! Register for free or click the "edit" link to contribute!

Arrowhead Research Corporation (ARWR)

This summary section needs content! Click Here to begin writing.

Have a question about Arrowhead Research Corporation? Ask it on the Message Board or Chat Room

Visit the Apple, Inc. page for an example of a complete article.

Today

Max

Company Analysis

You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.

The edit window has shortcut and help links if you need them.^[1] Be bold!

11/28/08 4:11 pm	ARROWHEAD RESEARCH CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhi (EDGAR Online)
11/19/08 4:11 pm	ARROWHEAD RESEARCH CORP Files SEC form 8-K, Entry into a Material Definitive Agreement (EDGAR Online)
11/19/08 7:11 am	Arrowhead CEO Provides Update on Tego Biosciences Corporation (Business Wire)
11/17/08 7:11 am	Arrowhead Research Corporation Retains The Piacente Group, Inc. as Strategic Investor Relations Consulting Firm (Business Wire)
11/12/08 7:11 am	Arrowhead CEO Provides Update on Nanotope, Inc. (Business Wire)
11/10/08 5:11 pm	ARROWHEAD RESEARCH CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)
11/04/08 7:11 am	Arrowhead CEO Provides Update on Majority Owned Subsidiary Unidym, Inc. (Business Wire)
11/03/08 7:11 am	Calando Pharmaceuticals to Present at 19th Annual Oppenheimer Healthcare Conference on November 4, 2008 (Business Wire)
10/31/08 3:10 pm	Arrowhead Research Corporation to Present at AeA Classic Financial Conference November 4 and 5, 2008 (Business Wire)
10/30/08 3:10 pm	ARROWHEAD RESEARCH CORP Files SEC form 8-K, Other Events (EDGAR Online)